Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Translational research : the journal of laboratory and clinical medicine

• Publication date

  2010-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.trsl.2010.05.008PMID 20875899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Paediatric non-alcoholic fatty liver disease

  2010cited by this paper
• The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease

  2009cited by this paper
• Pediatric nonalcoholic fatty liver disease in 2009.

  2009cited by this paper
• Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

  2009cited by this paper
• Childhood NAFLD: a ticking time-bomb?

  2009cited by this paper
• Elevated serum ALT in children presenting to the emergency unit: Relationship with NAFLD.

  2009cited by this paper
• Measures to Summarize and Compare the Predictive Capacity of Markers

  2009cited by this paper
• Nonalcoholic steatohepatitis in children: A multicenter clinicopathological study

  2009cited by this paper
• Logistic Regression Models

  2009cited by this paper
• The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

  2009cited by this paper
• Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.

  2009cited by this paper
• Histopathology of non-alcoholic fatty liver disease.

  2009cited by this paper
• Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention.

  2009cited by this paper
• Advances in pediatric nonalcoholic fatty liver disease

  2009cited by this paper
• Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.

  2009cited by this paper
• Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)?

  2008cited by this paper
• Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography

  2008cited by this paper
• Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C

  2008cited by this paper
• Non-invasive diagnosis of steatosis and fibrosis.

  2008cited by this paper
• Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.

  2008cited by this paper
• Diagnostic Accuracy of Serum Hyaluronic Acid, FIBROSpect II, and YKL-40 for Discriminating Fibrosis Stages in Chronic Hepatitis C

  2008cited by this paper
• The obesity epidemic and nonalcoholic fatty liver disease in children

  2008cited by this paper
• Pediatric Nonalcoholic Fatty Liver Disease

  2008cited by this paper
• Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis

  2008cited by this paper
• Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.

  2007cited by this paper
• Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

  2007cited by this paper
• Noninvasive biochemical markers of liver fibrosis.

  2006cited by this paper
• Hyaluronic Acid Predicts Hepatic Fibrosis in Children With Hepatic Disease

  2006cited by this paper
• NAFLD in children: A prospective clinical‐pathological study and effect of lifestyle advice

  2006cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non‐alcoholic fatty liver disease

  2005cited by this paper
• Fibrosis in chronic liver diseases: diagnosis and management.

  2005cited by this paper
• Noninvasive diagnosis of fibrosis in chronic liver disease

  2004cited by this paper
• Blind and ultrasound-guided percutaneous liver biopsy in children

  2003cited by this paper
• CDC growth charts: United States.

  2000cited by this paper
• CDC growth charts; United States

  2000cited by this paper
• Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology

  2000cited by this paper
• Regression models for ordinal responses: a review of methods and applications.

  1997cited by this paper
• Nonparametric Statistics for the Behavioral Sciences

  1959influential reference

• KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease

  2024cites this paper
• AASLD Practice Guideline on blood-based non-invasive liver disease assessments of hepatic fibrosis and steatosis.

  2024cites this paper
• Binding of different hyaluronan to CD44 mediates distinct cell adhesion dynamics under shear flow

  2023cites this paper
• Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges

  2023cites this paper
• Serologic biomarkers and scoring systems for hepatic fibrosis in obese children with nonalcoholic steatohepatitis

  2023cites this paper
• Densification: Hyaluronan Aggregation in Different Human Organs

  2022cites this paper
• Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques

  2022cites this paper
• Higher Levels of Plasma Hyaluronic Acid and N-terminal Propeptide of Type III Procollagen Are Associated With Lower Kidney Function in Children With Non-alcoholic Fatty Liver Disease

  2022cites this paper
• Paediatric non-alcoholic fatty liver disease: an approach to pathological evaluation

  2022cites this paper
• Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapy

  2022cites this paper
• Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease

  2022cites this paper
• Diagnostic accuracy of fibrosis tests in children with non‐alcoholic fatty liver disease: A systematic review

  2021cites this paper
• Advances on Nanomedicines for Diagnosis and Theranostics of Hepatic Fibrosis

  2021cites this paper
• Role of Biomarkers in Monitoring Liver Allograft Function

  2021cites this paper
• Noninvasive diagnostic tools for pediatric NAFLD: where are we now?

  2020cites this paper
• Association of novel markers of liver disease with neonatal liver disease in premature baboons, Papio sp.

  2020cites this paper
• Biomarkers in Pediatric NAFLD

  2020cites this paper
• Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study

  2020cites this paper
• A Liver Biopsy Validation Pilot Study of Shear Wave Elastography, APRI, FIB-4, and Novel Serum Biomarkers for Liver Fibrosis Staging in Children With Chronic Viral Hepatitis

  2020cites this paper
• Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges

  2020cites this paper
• Pediatric NAFLD: an overview and recent developments in diagnostics and treatment

  2019cites this paper
• MODERN NON-INVASIVE METHODS OF DIAGNOSTICS OF LIVER FIBROSIS IN CHILDREN

  2019cites this paper
• The search for noninvasive methods to identify liver fibrosis in children with nonalcoholic fatty liver disease.

  2018cites this paper
• Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design.

  2018cites this paper
• In Vivo Photoacoustic Imaging of Livers Using Biodegradable Hyaluronic Acid‐Conjugated Silica Nanoparticles

  2018cites this paper
• Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy

  2018cites this paper
• The role of ursodeoxycholic acid on cholestatic hepatic fibrosis in infant rats.

  2017cites this paper
• Correlation of four potential biomarkers of liver fibrosis with liver function and grade of hepatic fibrosis in a neonatal cholestatic rat model.

  2017cites this paper
• NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)

  2017cites this paper
• Pediatric Non-alcoholic Fatty Liver Disease: Current Thinking.

  2017cites this paper
• Hepatic fibrosis scores and serum biomarkers in pediatric hepatology

  2017cites this paper
• Cystic Fibrosis-related cirrhosis.

  2017cites this paper
• The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness

  2017cites this paper
• Late graft hepatitis and fibrosis in pediatric liver allograft recipients: Current concepts and future developments

  2016cites this paper
• Hyaluronic acid as a non-invasive biomarker of liver fibrosis.

  2016cites this paper
• Pediatric Non-alcoholic Fatty Liver Disease

  2016cites this paper
• Correlation analysis between four serum biomarkers of liver fibrosis and liver function in infants with cholestasis.

  2016cites this paper
• Hyaluronic acid algorithm-based models for assessment of liver fibrosis: translation from basic science to clinical application.

  2016cites this paper
• A Comprehensive Review of Noninvasive Liver Fibrosis Tests in Pediatric Nonalcoholic Fatty Liver Disease

  2015cites this paper
• Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease

  2015cites this paper
• Serum Levels of Glycosaminoglycans and Chondroitin Sulfate/Hyaluronic Acid Disaccharides as Diagnostic Markers for Liver Diseases

  2015cites this paper
• Enhanced liver fibrosis (ELF) test in obese children with ultrasound-proven liver steatosis.

  2015cites this paper
• Pediatric Non-Alcoholic Fatty Liver Disease

  2014cites this paper
• Non-alcoholic fatty liver disease

  2014cites this paper
• Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

  2014cites this paper
• Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease

  2014cites this paper
• Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease

  2014cites this paper
• Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease

  2013cites this paper
• HEPATIC STEATOSIS IN CHILDREN CLINICAL-BIOLOGICAL CORELATIONS AND LONG TERM EVOLUTIVE IMPLICATIONS

  2013cites this paper
• Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience.

  2013cites this paper
• Combination of Bard Scoring System and Transient Elastography or Serum Hyaluronic Acid for Diagnosis of Severe Fibrosis in Patients with NAFLD

  2013cites this paper
• Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.

  2013influential citation
• Novel Algorithm for Non-Invasive Assessment of Fibrosis in NAFLD

  2013cites this paper
• Hyaluronic Acid: From Biochemical Characteristics to its Clinical Translation in Assessment of Liver Fibrosis

  2013cites this paper
• A 360-degree overview of paediatric NAFLD: recent insights.

  2013cites this paper
• Levels of Serum Ceruloplasmin Associate With Pediatric Nonalcoholic Fatty Liver Disease

  2013cites this paper
• W DERMATOLOGII ESTETYCZNEJ I KOSMETOLOGII: INTRADERMOTERAPIA, SUPLEMENTACJA DOUSTNA ORAZ APLIKACJA ZEWN ĘTRZNA.

  2013cites this paper
• HEPATIC STEATOSIS IN CHILDREN CLINICAL-BIOLOGICAL CORELATIONS AND LONG TERM EVOLUTIVE IMPLICATIONS

  2013cites this paper
• Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease.

  2012cites this paper
• Feasibility study and control values of transient elastography in healthy children

  2012cites this paper
• Nonalcoholic fatty liver in children and adolescents: an overview.

  2012cites this paper
• Diagnosis of Nonalcoholic Fatty Liver Disease in Children and Adolescents: Position Paper of the ESPGHAN Hepatology Committee

  2012cites this paper
• Sensitive non‐invasive circulating markers in paediatric non‐alcoholic fatty liver disease

  2012cites this paper
• Liver fibrosis in paediatric liver diseases.

  2011cites this paper
• The Role of Serum Biomarkers in Predicting Fibrosis Progression in Pediatric and Adult Hepatitis C Virus Chronic Infection

  2011cites this paper
• Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.

  2011cites this paper
• Transient elastography for assessment of fibrosis in paediatric liver disease

  2011cites this paper
• Pathogen‐ or damage‐associated molecular patterns during nonalcoholic fatty liver disease development

  2011cites this paper
• Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients

  2011cites this paper
• Serum hyaluronic acid for the screening of progressive nonalcoholic steatohepatitis in children: a promising approach.

  2010cites this paper
• World Journal of Hepatology

  year unknowncites this paper